Dimension Therapeutics
Business Services · 51-200 Employees
View Company Info for Free
Overview
Phone Number
(617) 401-0011Website
www.dimensiontx.comRevenue
$14.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Dimension Therapeutics
Dimension Therapeutics, Inc., a gene therapy platform company, focuses on discovering and developing therapeutic products for people living with rare and metabolic diseases associated with the liver. The company's pipeline of programs includes DTX101, a lead gene therapy product candidate designed to deliver FIX gene expression in patients with hemophilia B; and DTX201, a FVIII gene therapy program for the treatment of hemophilia A. Its pipeline programs also comprise DTX301, a gene therapy product candidate for the treatment of ornithine transcarbamylase deficiency; DTX401, a gene therapy program for the treatment of glycogen storage disease type Ia; DTX501, gene therapy program for the treatment of patients with PKU; DTX701, a gene therapy program for the treatment of Wilson disease; and DTX601, a gene therapy program for the treatment of citrullinemia type I. Dimension Therapeutics, Inc. was founded in 2013 and is based in Cambridge,...Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Dimension Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Dimension Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check out if Dimension Therapeutics is spiking on competitors!
Check if Dimension Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Dimension Therapeutics launches new products
Click to see if Dimension Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Dimension Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Dimension Therapeutics
Earning: See what the market has to say on Dimension Therapeutics recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Dimension Therapeutics
Compare insights from companies similar to Dimension Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Dimension Therapeutics
$14.9M
51-200
Private
-
2013
N/A
<$5M
51-200
Private
$147.5M
2018
RR
Renuka RamanathanVice President Head of Corporate & Business Development
Company Profile Activity
Activity Insights
Dimension Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Dimension Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Dimension Therapeutics.
Dimension Therapeutics Tech Stack
A closer look at the technologies used by Dimension Therapeutics
See more technologies
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Dimension Therapeutics
Sign Up For FreeTo access detailed company insights
Dimension Therapeutics, Inc., a gene therapy platform company, focuses on discovering and developing therapeutic products for people living with rare and metabolic diseases associated with the liver. The company's pipeline of programs includes DTX101, a lead gene therapy product candidate designed to deliver FIX gene expression in patients with hem... Read More
